Pictet Asset Management’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.8M | Buy |
3,907,569
+2,279,356
| +140% | +$13.3M | 0.02% | 479 |
|
|
2025
Q1 | $13.7M | Buy |
1,628,213
+110,577
| +7% | +$932K | 0.02% | 580 |
|
|
2024
Q4 | $14.3M | Sell |
1,517,636
-110,241
| -7% | -$1.04M | 0.02% | 578 |
|
|
2024
Q3 | $17.4M | Sell |
1,627,877
-2,588,334
| -61% | -$27.7M | 0.02% | 523 |
|
|
2024
Q2 | $41.8M | Sell |
4,216,211
-2,551,162
| -38% | -$25.3M | 0.05% | 315 |
|
|
2024
Q1 | $79.9M | Sell |
6,767,373
-227,224
| -3% | -$2.68M | 0.09% | 234 |
|
|
2023
Q4 | $99.3M | Sell |
6,994,597
-1,402,914
| -17% | -$19.9M | 0.11% | 204 |
|
|
2023
Q3 | $102M | Buy |
+8,397,511
| New | +$102M | 0.13% | 188 |
|